编辑丨于靖
9月13日,Akero Therapeutics宣布旗下药物Efruxifermin(EFX,曾用名AKR-001)在IIb期HARMONY研究中,可改善肝硬化前期非酒精性脂肪性肝炎(NASH)患者的肝纤维化并防止疾病恶化,Efruxifermin 28mg和50mg剂量组均达到了改善肝脏纤维化的主要终点以及多个次要终点...查看全文
chuminhua2021-08-26 14:55
8月25日,Lipocine公司宣布,其在研疗法LPCN 1144,在治疗非酒精性脂肪性肝炎(NASH)男性患者的2期概念验证临床试验LiFT中获得积极结果。LPCN 1144是一种口服的睾酮前药。NASH是全球肝衰竭和肝移植的主要原因,是非酒精性脂肪性肝病(NAFLD)的一种更晚期状态,可进展为肝硬化,最终发展为肝癌。...查看全文
SnowBall2020Q42021-02-05 22:17
$Lipocine(LPCN)$ 号称口服睾丸酮对于老年男性新冠患者有帮助,但是炒作第一波已经过了。口服治疗方案具体咋样还没有仔细研究。查看全文
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-05-16 AccNo: 0001144204-16-102095 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-05-10 AccNo: 0001144204-16-100127 Size: 1 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-05-09 AccNo: 0001144204-16-099960 Size: 82 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-09 AccNo: 0001144204-16-099991 Size: 6 MB 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-05-02 AccNo: 0001144204-16-098123 Size: 86 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-29 AccNo: 0001144204-16-097385 Size: 311 KB 网页链接
$LIPOCINE INC NEW(LPCN)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-29 AccNo: 0001144204-16-097384 Size: 1 MB 网页链接
$LIPOCINE INC NEW(LPCN)$ 美东时间 2016-04-13 15:40 Lipocine Inc at Needham Healthcare Conference 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-04-12 AccNo: 0001144204-16-093872 Size: 6 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$LIPOCINE INC NEW(LPCN)$ 8-K - Current report Filed: 2016-04-01 AccNo: 0001144204-16-092307 Size: 906 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接